Joinn Laboratories(China)Co.,Ltd. (SHA:603127)

China flag China · Delayed Price · Currency is CNY
34.20
-0.98 (-2.79%)
Jul 30, 2025, 2:45 PM CST
-2.79%
Market Cap23.43B
Revenue (ttm)1.98B
Net Income (ttm)387.42M
Shares Out733.37M
EPS (ttm)0.51
PE Ratio65.33
Forward PE69.05
Dividend0.03 (0.08%)
Ex-Dividend DateJul 31, 2024
Volume57,850,916
Average Volume38,686,617
Open34.10
Previous Close35.18
Day's Range32.34 - 37.00
52-Week Range13.02 - 35.20
Beta0.72
RSI75.74
Earnings DateAug 27, 2025

About SHA:603127

Joinn Laboratories(China)Co.,Ltd. provides preclinical and non-clinical services in the United States, the People’s Republic of China, and internationally. It operates through three segments: Non-Clinical Studies Services; Clinical Trial and Related Services; and Sales of Research Models. The Non-Clinical Studies Services segment offers drug safety assessment, drug metabolism and pharmacokinetics DMPK studies, and pharmacology and efficacy studies. The Clinical Trial and Related Services segment provides clinical CRO services, co-managed phase ... [Read more]

Sector Healthcare
Founded 1995
Employees 2,652
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 603127
Full Company Profile

Financial Performance

In 2024, SHA:603127's revenue was 2.02 billion, a decrease of -15.07% compared to the previous year's 2.38 billion. Earnings were 74.08 million, a decrease of -81.34%.

Financial Statements

News

There is no news available yet.